ALOMIDE

This brand name is authorized in Canada, Finland, Turkey, United States, South Africa

Active ingredients

The drug ALOMIDE contains one active pharmaceutical ingredient (API):

1 Lodoxamide UNII 50LV9A548L - LODOXAMIDE TROMETHAMINE

Lodoxamide is a mast cell stabiliser that inhibits the in vivo Type I immediate hypersensitivity reaction in animals and man. Read about Lodoxamide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ALOMIDE Eye drops, solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01GX05	Lodoxamide	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics
Discover more medicines within S01GX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00893560
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 469494
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699504612011
Country: US	FDA, National Drug Code	Identifier(s): 0065-0345
Country: ZA	Health Products Regulatory Authority	Identifier(s): X/15.4/26